Market Tracker

04/29 5:16pm ET

Dynavax Technologies Corp (NASDAQ:DVAX)

16.41
Delayed Data
As of 4:00pm ET
 -1.12 / -6.39%
Today’s Change
15.52
Today|||52-Week Range
32.49
-32.08%
Year-to-Date

Today’s Trading

Previous close17.53
Today’s open17.50
Day’s range16.10 - 17.70
Volume1,524,343
Average volume (3 months)1,105,978
Market cap$674.8M
Dividend yield--
Data as of 4:00pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)+5.80%
Earnings growth (this year)+22.56%
Earnings growth (next 5 years)--
Revenue growth (last year)-63.29%
P/E ratioNM
Price/Sales196.15
Price/Book3.60

Competitors

 Today’s
change
Today’s
% change
SCLNSciClone Pharmaceuti...+0.01+0.08%
EPZMEpizyme Inc-0.64-5.79%
SRPTSarepta Therapeutics...+0.39+2.83%
MGNXMacroGenics Inc-0.28-1.34%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 5, 2016
EPS forecast (this quarter)-$0.59
Annual revenue (last year)$4.1M
Annual profit (last year)-$106.8M
Net profit margin-2,636.89%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts